IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.36 -0.45 (-1.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

IDEAYA Biosciences (IDYA) Change in Accured Expenses (2018 - 2026)

Updated

IDEAYA Biosciences' Change in Accured Expenses was $7.79 million in Q2 2026, up 60.9% from $4.84 million a year earlier and up 185.8% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Change in Accured Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, IDEAYA Biosciences' Change in Accured Expenses was $13.23 million through Jun 30, 2026, up 2.7% year-over-year; for FY2025, it was $10.43 million, down 3.4% from FY2024.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $10.79 million in FY2024 (+560.2%), $1.64 million in FY2023 (-64.2%), $4.57 million in FY2022 (+8.5%) and $4.21 million in FY2021 (+40.8%).
  • The Q2 2026 figure marks the highest quarterly Change in Accured Expenses in data going back to Q3 2018.
  • Compared with a year earlier, Change in Accured Expenses was higher in three of the last six quarters, with growth averaging 32.8%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q4 2023 (growth of 668.1%); the worst was Q4 2021 (a decline of 73.6%).
  • Per Business Quant data, IDYA's Change in Accured Expenses in the three quarters before Q2 2026 was $2.73 million (Q1 2026), -$4.8 million (Q4 2025) and $7.51 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 IDEAYA Biosciences 3.60 Bn 674.16 Mn - 7.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.79 Mn
Mar 31, 2026 2.73 Mn
Dec 31, 2025 -4.80 Mn
Sep 30, 2025 7.51 Mn
Jun 30, 2025 4.84 Mn
Mar 31, 2025 2.88 Mn
Dec 31, 2024 2.27 Mn
Sep 30, 2024 2.90 Mn
Jun 30, 2024 6.90 Mn
Mar 31, 2024 -1.27 Mn
Dec 31, 2023 2.48 Mn
Sep 30, 2023 2.41 Mn
Jun 30, 2023 -2.84 Mn
Mar 31, 2023 -419,000.00
Dec 31, 2022 323,000.00
Sep 30, 2022 1.15 Mn
Jun 30, 2022 2.96 Mn
Mar 31, 2022 140,000.00
Dec 31, 2021 476,000.00
Sep 30, 2021 2.01 Mn
API Access

IDEAYA Biosciences Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEY